Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers

Published:2017-03 Issue: Volume:172 Page:9-13
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Babalonis Shanna,Haney Margaret,Malcolm Robert J.,Lofwall Michelle R.,Votaw Victoria R.,Sparenborg Steven,Walsh Sharon L.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference31 articles.

1. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients;Bergamaschi;Neuropsychopharmacology,2011

2. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology;Bhattacharyya;Neuropsychopharmacology,2010

3. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide;Bisogno;Br. J. Pharmacol.,2001

4. Controlled clinical trial of cannabidiol in Huntington’s disease;Consroe;Pharmacol. Biochem. Behav.,1991

5. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts;Cooper;Drug Alcohol Depend.,2009

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Benefits and Safety of Medical Cannabis Products: A Narrative Review on Natural Extracts;Pain and Therapy;2024-08-03

2. New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-07

3. A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids;Frontiers in Psychiatry;2024-06-10

4. The Development of Cannabinoids as Therapeutic Agents in the United States;Pharmacological Reviews;2024-06-07

5. Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder;Expert Opinion on Emerging Drugs;2024-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3